tradmap

BFLY Butterfly Network, Inc.

$6.78 +5.78%

Data as of close

Healthcare · X-Ray Apparatus & Tubes & Related Irradiation Apparatus

Butterfly Network, Inc. (BFLY) is a healthcare company in the X-Ray Apparatus & Tubes & Related Irradiation Apparatus industry, with a market capitalization of $1.8 billion. Shares last traded at $6.78, 33.5% below their 52-week high. Over the past year the stock is up 130.4%. Net profit margin is -43.6%, below the peer median of -16.8%. Revenue grew 19.0% year over year.

Market Cap
$1.8B
Shares Out
267.5M
EPS (TTM)
-$0.21
P/E (TTM)*
—
P/S Ratio
14.70
P/B Ratio
9.82
Dividend / Share
—
Dividend Yield
—
52-Week High
$10.19
52-Week Low
$1.91
Volume (venue)
383,987
Avg Vol (3m, venue)
356,541.873

* P/E (TTM) = market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year — the same basis as the peer table and the screener, so it can differ from price ÷ EPS.

Performance

1W
-13.42%
1M
-22.13%
3M
-18.37%
6M
+48.90%
YTD
+78.52%
1Y
+130.44%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
43.36
SMA (50)
$7.90
SMA (200)
$6.08
Price vs SMA50
-14.26%
Price vs SMA200
+11.50%
ATR (14)
$0.58

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue
$123M
Net Income
-$54M
Gross Margin
70.3%
Operating Margin
-46.9%
Net Margin
-43.6%
Return on Equity
-29.1%
Return on Assets
-18.6%
Current Ratio
3.58
Debt / Equity
0.56
Revenue Growth (YoY)
+19.0%

Trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year; revenue is the fiscal-year figure where quarterly revenue covers under half of it (typical for banks, insurers and REITs), and margins are taken on it; latest reported period ends 2026-09-30. Source: SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

PeriodEPS (diluted)Reported
Q3 2026 -$0.05 2026-10-29
Q2 2026 -$0.05 2026-07-30
Q1 2026 -$0.05 2026-04-30
Q4 2025 (derived) -$0.06 2026-02-27
FY 2025 -$0.31 2026-02-27
Q3 2025 -$0.13 2025-10-31

Q4 marked "derived" = fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive, so it can differ by a cent or two from the issuer's own Q4.

Full earnings history →

X-Ray Apparatus & Tubes & Related Irradiation Apparatus peers

BFLY vs 4 industry peers (X-Ray Apparatus & Tubes & Related Irradiation Apparatus), by market cap. Data as of close

P/S vs peers
14.70 / 8.25 med
+78% premium
Net margin vs peers
-43.6% / -16.8% med
below median
1–4 of 4
GEHCGE HealthCare$38.8B18.011.7910.0%+6.41%
PHGKoninklijke Philips Nv$29.9B———+9.03%
BFLYButterfly Network, Inc.$1.8B—14.70-43.6%+5.78%
NNOXNano-X Imaging Ltd.$20M———-7.69%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.